BIOTIA-ID, The Next Generation of Joint Fluid Diagnostics

This Research Use Only (RUO) assay identifies key targets causing joint infections with high sensitivity and specificity using next-generation sequencing technology.

Joint infections are often caused by hard to detect microbes, polymicrobial infections, or atypical pathogens. BIOTIA-ID Joint Fluid NGS Assay was developed to detect a wide variety of disease causing pathogens including fastidious, anaerobic bacteria and fungi.

A single test for comprehensive pathogen diagnostics

Clinical use-cases include patients with symptoms of prosthetic joints infections, and patients with suspected prosthetic joint infections and negative culture results.

At a glance

More accurate and sensitive than culture


Highly sensitive pathogen detection for a wide array of joint infection causing agents.



Polymicrobial pathogen detection, anaerobe detection, and atypical pathogen detection.

Antimicrobial resistance markers


Allows for an detection of key AMR markers.



BIOTIA-ID Joint Fluid is a Research Use Only tool.

Contact us for more information


Research Use Only

This research use only (RUO) assay is only intended to be used for research and is not intended to provide diagnostic results or guide treatment of patients. This assay was developed and its performance characteristics determined by Biotia. The RUO assay has not been cleared or approved by the FDA, nor is it required to be. The Biotia Laboratory is certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA ’88) and is accredited to perform high-complexity clinical laboratory testing.